Olema Share Price

Olema Share Price

NASDAQ: OLMA | Small Cap | Healthcare
$7.01
-$0.17 (-2.44%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Olema Stock Performance

Open
$7.01
Prev. Close
$7.18
Circuit Range
N/A
Day Range
$6.96 - $7.36
Year Range
$6.24 - $36.15
Volume
94,358
Average Traded
$7.09

Olema Share Price Today

As of 21 November 2026, Olema Oncology, Inc.'s share price is $7.01. The stock opened at $7.01, compared to its previous close of $7.18. During today's trading session, Olema Oncology, Inc.'s share price traded between $6.96 and $7.36, with an average price of $7.16. Over the past 52 weeks, the stock has recorded a high of $36.15 and a low of $6.24. In terms of performance, Olema Oncology, Inc.'s share price has declined by 46.89% over the last six months and is down 75.28% on a year-on-year basis.

Olema Share Price Chart

Line chart of the Olema price trend over the selected period. The price fell overall, ranging from 6.94 to 7.34, ending at 7.01.
$6.96$7.36
L
Show Current Price
H

Olema Stock Fundamentals & Key Indicators

Market Cap
$609.91M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.69
Revenue (TTM)
$0.00
Return On Equity (TTM)
-63.97%
Profit Margin
N/A
Debt to Equity
0.01
Quarterly Earnings Growth YoY
-59.79%

Olema Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$46.06-$53.09-$63.20-$73.60
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-15.26%-19.04%-16.46%

Olema Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$104.79-$96.66-$129.47-$162.45
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A7.76%-33.94%-25.47%

Olema Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets17.9812.5110.436.75
Current Assets515.45438.47266.51208.9
Total Assets533.43450.98276.95215.65
Non Current Liabilities3.070.261.431.55
Current Liabilities51.841.7621.6216.55
Total Liabilities54.8742.0223.0518.1
Shareholders' Equity478.56408.96253.9197.55

Olema Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-146.72-104.35-83.73-82.07
Investing-155.76-93.53-4.8591.48
Financing211.3268.82133.420.48

About Olema

Olema Oncology Inc is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. Olema is advancing a pipeline of novel therapies by leveraging its deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance. The company's lead product candidate, palazestrant (OP-1250), is a proprietary, orally available complete estrogen receptor antagonist (CERAN) and a selective estrogen receptor degrader (SERD), is currently in two Phase 3 clinical trials. In addition, Olema is focused in developing OP-3136, a potent lysine acetyltransferase 6 (KAT6) inhibitor.

Olema Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$7.05
$7.03
+0.50%
Oct 2026
$8.64
$6.99
-19.42%
Sep 2026
$10.40
$8.68
-19.53%
Aug 2026
$11.39
$10.78
-5.69%
Jul 2026
$12.59
$11.43
-8.78%
Jun 2026
$13.08
$12.53
-5.08%
May 2026
$14.38
$13.20
-8.59%
Apr 2026
$15.14
$14.44
-3.15%
Mar 2026
$23.72
$14.91
-38.43%
Feb 2026
$24.16
$24.21
-5.81%
Jan 2026
$24.82
$25.71
+2.72%
Dec 2025
$27.72
$25.03
-11.74%

Olema Share Price FAQs